Abstract

Polyamines have fundamental roles in brain homeostasis as key modulators of cellular excitability. Several studies have suggested alterations in polyamine metabolism in stress related disorders, suicide, depression, and neurodegeneration, making the pharmacological modulation of polyamines a highly appealing therapeutic strategy. Polyamines are small aliphatic molecules that can modulate cationic channels involved in neuronal excitability. Previous indirect evidence has suggested that polyamines can modulate anionic GABAA receptors (GABAARs), which mediate inhibitory signaling and provide a direct route to reduce hyperexcitability. Here, we attempted to characterize the effect that spermine, the polyamine with the strongest reported effect on GABAARs, has on human postmortem native GABAARs. We microtransplanted human synaptic membranes from the dorsolateral prefrontal cortex of four cases with no history of mental or neurological disorders, and directly recorded spermine effects on ionic GABAARs responses on microtransplanted oocytes. We show that in human synapses, inhibition of GABAARs by spermine was better explained by alkalization of the extracellular solution. Additionally, spermine had no effect on the potentiation of GABA-currents by diazepam, indicating that even if diazepam binding is enhanced by spermine, it does not translate to changes in functional activity. Our results clearly demonstrate that while extracellular spermine does not have direct effects on human native synaptic GABAARs, spermine-mediated shifts of pH inhibit GABAARs. Potential spermine-mediated increase of pH in synapses in vivo may therefore participate in increased neuronal activity observed during physiological and pathological states, and during metabolic alterations that increase the release of spermine to the extracellular milieu.

Details

Title
Electrophysiological evaluation of extracellular spermine and alkaline pH on synaptic human GABAA receptors
Author
Limon, A 1   VIAFID ORCID Logo  ; Delbruck, E 2 ; Yassine, A 2 ; Pandya, D 3 ; Myers, R M 4 ; Barchas, J D 5 ; Lee, F 5 ; Schatzberg 6 ; Watson, S J 7   VIAFID ORCID Logo  ; Akil, H 7 ; Bunney, W E 2 ; Vawter, M P 2 ; Sequeira, A 2 

 Department of Psychiatry and Human Behavior. School of Medicine, University of California Irvine, Irvine, USA; Department of Neurology, Mitchel Center for Neurodegenerative Diseases, School of Medicine, University of Texas Medical Branch at Galveston, Galveston, USA 
 Department of Psychiatry and Human Behavior. School of Medicine, University of California Irvine, Irvine, USA 
 Department of Neurology, Mitchel Center for Neurodegenerative Diseases, School of Medicine, University of Texas Medical Branch at Galveston, Galveston, USA 
 HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA 
 Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA 
 Department of Psychiatry & Behavioral Sciences, Stanford University, Palo Alto, CA, USA 
 Molecular and Behavioral Neurosciences Institute, University of Michigan, Ann Arbor, MI, USA 
Pages
1-9
Publication year
2019
Publication date
Sep 2019
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2285070114
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.